Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001415889-24-015092

Options or other derivatives

  • Director acquired 18,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2024-05-29 Grant or award · Stock Option (right to buy) +18,600 18,600 I
Loading xslF345X05/form4-05312024_100503.xml…